$16.89
0.040.24%
At close: Aug 28, 5:00 PM EST
$16.89
N/A
After Hours: 4:00 PM EST
Integra Lifesciences Holdings Corp
IARTNASDAQ
Integra Lifesciences Earnings & Forecasts
Integra Lifesciences (IART) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Integra Lifesciences Guidance
Integra Lifesciences (IART) last issued guidance on July 29, 2026 for Q3 2026. The company guided earnings per share in the range of $0.53 - $0.61, compared to a consensus EPS estimate of $0.56. Integra Lifesciences also guided revenue in the range of $410M - $425M for the period.
Compared to prior guidance, Integra Lifesciences lowered its revenue forecast from a prior range of $1.65B - $1.7B.
Integra Lifesciences has issued 37 guidance updates between October 26, 2022 and July 29, 2026. During this period, the company raised its outlook 10 times and lowered it 19 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.48 | $0.41 | $0.80 | $0.43 |
| Actual | $0.56 | $0.54 | $0.83 | $0.54 |
| Surprise | +16.7% | +31.7% | +3.75% | +25.6% |
| Revenue | ||||
| Estimate | $418.0M | $381.7M | $431.5M | $414.5M |
| Actual | $418.8M | $391.9M | $434.9M | $402.1M |
| Surprise | +0.18% | +2.67% | +0.79% | -3.00% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.56 | $0.80 | $0.50 | $0.56 |
| Revenue | ||||
| Consensus | $416.4M | $447.5M | — | — |
